Healthcare · Medical - Diagnostics & Research
Price
$195.67
Market Cap
$138.5B
Employees
61,000
Beta
0.83
Avg Volume
4,595,506
CEO
Rainer Blair
Business Description
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
Business History
Price Overview
Last updated: Jun 28, 2026 12:13pm (just now)$195.67
+2.86 (+1.48%)
Day Range
$192.29 – $196.10
52-Week Range
$160.93 – $242.80
50-Day MA
$178.79
200-Day MA
$203.93
Volume
3,252,821.00
Analyst Price Targets
Low
$200.00
Consensus
$230.89
High
$265.00
(52 analysts)
Share Structure
Outstanding
707,770,627.00
Float
630,630,706.00
Free Float
89.1%
High free float
— 89.1% of shares trade freely, ~10.9% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
APIStock Price / EPS (Diluted)
37.55
Stock Price: $195.67
EPS (Diluted): 5.07
EPS (Diluted): 5.07
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
3.08
Stock Price: $195.67
Total Equity: $52.53B
Shares: 711,000,000
Total Equity: $52.53B
Shares: 711,000,000
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
22.77
Market Cap: $138.49B
Total Debt: $18.42B
Cash: $4.62B
EBITDA: $6.95B
Total Debt: $18.42B
Cash: $4.62B
EBITDA: $6.95B
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$175.7B
Market Cap: $138.49B
Total Debt: $18.42B
Cash: $4.62B
Total Debt: $18.42B
Cash: $4.62B
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
60.9%
Gross Profit: $14.97B
Revenue: $24.57B
Revenue: $24.57B
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
20.9%
Operating Income: $5.14B
Revenue: $24.57B
Revenue: $24.57B
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
14.7%
Net Income: $3.61B
Revenue: $24.57B
Revenue: $24.57B
ROE (Profit from shareholder equity)
APINet Income / Total Equity
7.1%
Net Income: $3.61B
Total Equity: $52.53B
Total Equity: $52.53B
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
5.7%
Operating Income: $5.14B
Tax Rate: 14.6%
Equity: $52.53B
Total Debt: $18.42B
Cash: $4.62B
Tax Rate: 14.6%
Equity: $52.53B
Total Debt: $18.42B
Cash: $4.62B
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
1.87
Current Assets: $12.76B
Current Liabilities: $6.81B
Current Liabilities: $6.81B
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.35
Short-Term Debt: $2.00M
Long-Term Debt: $18.42B
Total Debt: $18.42B
Total Equity: $52.53B
Long-Term Debt: $18.42B
Total Debt: $18.42B
Total Equity: $52.53B
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$34.55
Revenue: $24.57B
Shares: 711,000,000
Shares: 711,000,000
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$73.89
Total Equity: $52.53B
Shares: 711,000,000
Shares: 711,000,000
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$7.40
Operating CF: $6.42B
CapEx: -$1.16B
Shares: 711,000,000
CapEx: -$1.16B
Shares: 711,000,000
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.5%
Last Dividend: N/A
Stock Price: $195.67
Stock Price: $195.67
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: $3.61B
Net Income: $3.61B
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares DHR against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 28, 2026 3:03am (9h ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $29.5B | $26.6B | $23.9B | $23.9B | $24.6B |
| Cost of Revenue | $11.5B | $10.5B | $9.9B | $9.7B | $9.6B |
| Gross Profit | $18.0B | $16.2B | $14.0B | $14.2B | $15.0B |
| Operating Expenses | $9.9B | $8.7B | $8.8B | $9.0B | $9.8B |
| Operating Income | $8.1B | $7.5B | $5.3B | $5.2B | $5.1B |
| Net Income | $6.4B | $7.2B | $4.8B | $3.9B | $3.6B |
| EBITDA | $10.0B | $9.5B | $7.5B | $7.3B | $6.9B |
| EPS | $8.77 | $9.80 | $6.44 | $5.33 | $5.07 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 28, 2026 3:02am (9h ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $2.6B | $6.0B | $5.9B | $2.1B | $4.6B |
| Total Current Assets | $11.6B | $15.9B | $13.9B | $9.5B | $12.8B |
| Total Assets | $83.2B | $84.4B | $84.5B | $77.5B | $83.5B |
| Current Liabilities | $8.1B | $8.4B | $8.3B | $6.8B | $6.8B |
| Long-Term Debt | $22.2B | $19.1B | $16.7B | $15.5B | $18.4B |
| Total Liabilities | $38.0B | $34.3B | $31.0B | $28.0B | $30.9B |
| Total Equity | $45.2B | $50.1B | $53.5B | $49.5B | $52.5B |
| Retained Earnings | $32.8B | $39.2B | $41.1B | $44.2B | $46.9B |
Cash Flow (Annual)
Last updated: Jun 28, 2026 3:04am (9h ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $8.4B | $8.5B | $7.2B | $6.7B | $6.4B |
| Capital Expenditure | -$1.3B | -$1.2B | -$1.4B | -$1.4B | -$1.2B |
| Free Cash Flow | $7.1B | $7.4B | $5.8B | $5.3B | $5.3B |
| Acquisitions (net) | -$10.9B | -$637.0M | -$5.6B | -$558.0M | $9.0M |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | -$6.0B | -$3.1B |
| Net Change in Cash | -$3.4B | $3.4B | -$131.0M | -$3.8B | $2.5B |
Analyst Estimates (Annual)
Last updated: Jun 28, 2026 12:13pm (just now)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$27.1B $26.7B – $28.9B
|
$28.9B $28.0B – $29.8B
|
$30.7B $30.0B – $31.6B
|
$31.7B $31.0B – $32.6B
|
| EBITDA |
$8.7B $8.5B – $9.2B
|
$9.2B $8.9B – $9.5B
|
$9.8B $9.6B – $10.1B
|
$10.1B $9.9B – $10.4B
|
| Net Income |
$6.5B $6.4B – $6.7B
|
$6.3B $6.3B – $8.1B
|
$7.7B $7.5B – $8.0B
|
$8.2B $7.9B – $8.5B
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 28, 2026 3:03am (9h ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | -9.5% | -10.3% | -0.1% | +2.9% |
| Gross Profit Growth | -9.8% | -13.3% | +1.2% | +5.4% |
| Operating Income Growth | -6.4% | -29.9% | -1.8% | -0.9% |
| Net Income Growth | +12.1% | -33.9% | -18.2% | -7.3% |
| EBITDA Growth | -5.2% | -20.9% | -3.0% | -4.5% |
Insider Trading (Recent)
Type codes
PPurchase
SSale
AAward / grant
MOption exercise
FIn-kind (tax)
CConversion
GGift
DReturn to issuer
All SEC Form 4 codes
Open market
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
Compensation (Rule 16b-3)
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
Other exempt
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
Other
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-05-15 | FILLER LINDA | A-Award | 680.00 | $0.00 | $0 |
| 2026-05-15 | FILLER LINDA | A-Award | 1,699.00 | $161.91 | $275,085 |
| 2026-05-15 | Couchara Georgeann | F-InKind | 281.00 | $161.91 | $45,497 |
| 2026-05-15 | Stevens Raymond C | A-Award | 680.00 | $0.00 | $0 |
| 2026-05-15 | Stevens Raymond C | A-Award | 1,699.00 | $161.91 | $275,085 |
| 2026-05-15 | SPOON ALAN G | A-Award | 680.00 | $0.00 | $0 |
| 2026-05-15 | SPOON ALAN G | A-Award | 1,699.00 | $161.91 | $275,085 |
| 2026-05-15 | Sanders A Shane | A-Award | 680.00 | $0.00 | $0 |
| 2026-05-15 | Sanders A Shane | A-Award | 1,699.00 | $161.91 | $275,085 |
| 2026-05-15 | List Teri | A-Award | 680.00 | $0.00 | $0 |
| 2026-05-15 | List Teri | A-Award | 1,699.00 | $161.91 | $275,085 |
| 2026-05-15 | Zerhouni Elias A. | A-Award | 680.00 | $0.00 | $0 |
| 2026-05-15 | Zerhouni Elias A. | A-Award | 1,699.00 | $161.91 | $275,085 |
| 2026-05-15 | Dewan Feroz | A-Award | 680.00 | $0.00 | $0 |
| 2026-05-15 | Dewan Feroz | A-Award | 1,699.00 | $161.91 | $275,085 |
| 2026-05-15 | Lamanna Charles W | A-Award | 1,699.00 | $161.91 | $275,085 |
| 2026-05-15 | Lamanna Charles W | A-Award | 680.00 | $0.00 | $0 |
| 2026-05-01 | SPOON ALAN G | M-Exempt | 3,298.00 | $71.88 | $237,060 |
| 2026-05-01 | SPOON ALAN G | S-Sale | 1,358.00 | $174.67 | $237,207 |
| 2026-05-01 | SPOON ALAN G | M-Exempt | 3,298.00 | $71.88 | $237,060 |
Dividend History (Last 20)
Last updated: Jun 21, 2026 6:57pm (6d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-06-26 | $0.40 | 2026-05-05 | 2026-06-26 | 2026-07-31 |
| 2026-03-27 | $0.40 | 2026-02-24 | 2026-03-27 | 2026-04-24 |
| 2025-12-26 | $0.32 | 2025-12-09 | 2025-12-26 | 2026-01-30 |
| 2025-09-26 | $0.32 | 2025-09-09 | 2025-09-26 | 2025-10-31 |
| 2025-06-27 | $0.32 | 2025-05-06 | 2025-06-27 | 2025-07-25 |
| 2025-03-28 | $0.32 | 2025-02-20 | 2025-03-28 | 2025-04-25 |
| 2024-12-27 | $0.27 | 2024-12-10 | 2024-12-27 | 2025-01-31 |
| 2024-09-27 | $0.27 | 2024-09-10 | 2024-09-27 | 2024-10-25 |
| 2024-06-28 | $0.27 | 2024-05-07 | 2024-06-28 | 2024-07-26 |
| 2024-03-27 | $0.27 | 2024-02-21 | 2024-03-28 | 2024-04-26 |
| 2023-12-28 | $0.24 | 2023-12-05 | 2023-12-29 | 2024-01-26 |
| 2023-10-11 | $0.27 | 2023-09-12 | 2023-10-12 | 2023-10-27 |
| 2023-06-29 | $0.27 | 2023-05-09 | 2023-06-30 | 2023-07-28 |
| 2023-03-30 | $0.27 | 2023-02-22 | 2023-03-31 | 2023-04-28 |
| 2022-12-29 | $0.25 | 2022-12-06 | 2022-12-30 | 2023-01-27 |
| 2022-09-29 | $0.25 | 2022-09-13 | 2022-09-30 | 2022-10-28 |
| 2022-06-23 | $0.25 | 2022-05-10 | 2022-06-24 | 2022-07-29 |
| 2022-03-24 | $0.25 | 2022-02-23 | 2022-03-25 | 2022-04-29 |
| 2021-12-29 | $0.21 | 2021-12-07 | 2021-12-30 | 2022-01-28 |
| 2021-09-29 | $0.21 | 2021-09-14 | 2021-09-30 | 2021-10-29 |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for DHR — it's generated by the pipeline (
market-narrative step).
No community reviews yet for DHR.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30